Case Studies in the Management of Metastatic Breast Cancer with Eribulin

Outcomes for triple-negative or hormone-refractory metastatic breast cancer (MBC) are poor and treatment options are limited. Described herein are cases of two women who developed MBC following adjuvant chemotherapy and endocrine therapy for human epidermal growth factor receptor 2 (HER2)-negative d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilks, Sharon, McIntyre, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607072/
https://www.ncbi.nlm.nih.gov/pubmed/26508896
http://dx.doi.org/10.4137/CMO.S27962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607072/
https://www.ncbi.nlm.nih.gov/pubmed/26508896
http://dx.doi.org/10.4137/CMO.S27962

Ejemplares similares